228 related articles for article (PubMed ID: 17194447)
1. WNK1 and WNK4 modulate CFTR activity.
Yang CL; Liu X; Paliege A; Zhu X; Bachmann S; Dawson DC; Ellison DH
Biochem Biophys Res Commun; 2007 Feb; 353(3):535-40. PubMed ID: 17194447
[TBL] [Abstract][Full Text] [Related]
2. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
[TBL] [Abstract][Full Text] [Related]
3. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
Argaiz ER; Chavez-Canales M; Ostrosky-Frid M; Rodríguez-Gama A; Vázquez N; Gonzalez-Rodriguez X; Garcia-Valdes J; Hadchouel J; Ellison D; Gamba G
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F734-F745. PubMed ID: 29846116
[TBL] [Abstract][Full Text] [Related]
4. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW
J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520
[TBL] [Abstract][Full Text] [Related]
5. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
Yang CL; Zhu X; Ellison DH
J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
[TBL] [Abstract][Full Text] [Related]
6. Comparison of WNK4 and WNK1 kinase and inhibiting activities.
Wang Z; Yang CL; Ellison DH
Biochem Biophys Res Commun; 2004 May; 317(3):939-44. PubMed ID: 15081430
[TBL] [Abstract][Full Text] [Related]
7. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
8. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
[TBL] [Abstract][Full Text] [Related]
9. Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4.
Rafael C; Soukaseum C; Baudrie V; Frère P; Hadchouel J
Sci Rep; 2018 Feb; 8(1):3249. PubMed ID: 29459793
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.
Golbang AP; Cope G; Hamad A; Murthy M; Liu CH; Cuthbert AW; O'shaughnessy KM
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1369-76. PubMed ID: 16788137
[TBL] [Abstract][Full Text] [Related]
11. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
Vitari AC; Deak M; Morrice NA; Alessi DR
Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.
Wilson FH; Kahle KT; Sabath E; Lalioti MD; Rapson AK; Hoover RS; Hebert SC; Gamba G; Lifton RP
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):680-4. PubMed ID: 12515852
[TBL] [Abstract][Full Text] [Related]
13. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.
Hadchouel J; Soukaseum C; Büsst C; Zhou XO; Baudrie V; Zürrer T; Cambillau M; Elghozi JL; Lifton RP; Loffing J; Jeunemaitre X
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18109-14. PubMed ID: 20921400
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport.
Yang CL; Zhu X; Wang Z; Subramanya AR; Ellison DH
J Clin Invest; 2005 May; 115(5):1379-87. PubMed ID: 15841204
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders.
Kim Y; Jun I; Shin DH; Yoon JG; Piao H; Jung J; Park HW; Cheng MH; Bahar I; Whitcomb DC; Lee MG
Cell Mol Gastroenterol Hepatol; 2020; 9(1):79-103. PubMed ID: 31561038
[TBL] [Abstract][Full Text] [Related]
16. WNK kinases influence TRPV4 channel function and localization.
Fu Y; Subramanya A; Rozansky D; Cohen DM
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1305-14. PubMed ID: 16403833
[TBL] [Abstract][Full Text] [Related]
17. WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia.
Choate KA; Kahle KT; Wilson FH; Nelson-Williams C; Lifton RP
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):663-8. PubMed ID: 12522152
[TBL] [Abstract][Full Text] [Related]
18. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
19. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
20. WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
Vidal-Petiot E; Elvira-Matelot E; Mutig K; Soukaseum C; Baudrie V; Wu S; Cheval L; Huc E; Cambillau M; Bachmann S; Doucet A; Jeunemaitre X; Hadchouel J
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14366-71. PubMed ID: 23940364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
